• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Progen Pharmaceuticals Ltd

+ Add to Watchlist


0.1560 USD 0.0040 2.50%

As of 20:10:06 ET on 01/22/2015.

Snapshot for Progen Pharmaceuticals Ltd (PGLA)

Open: 0.1600 Day's Range: 0.1560 - 0.1600 Volume: 7,350
Previous Close: 0.1600 52wk Range: 0.1500 - 1.8600 1-Yr Rtn: -52.13%

Stock Chart for PGLA

No chart data available.
  • PGLA:US 0.1560
  • 1D
  • 1M
  • 1Y
Interactive PGLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PGLA

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 8.62
Shares Outstanding (M) 55.29
30 Day Average Volume 2,347
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PGLA

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PGLA

Progen Pharmaceuticals Limited is involved in the discovery, research and development of potential biopharmaceutical therapeutics for the treatment of human diseases. The Company also provides contract services related to the process development, manufacture and quality assurance of biological products.

Indrajit Solomon Arulampalam "Jitto"ChairmanLeslie TillackCEO:Pharmasynth
Heng Hsin TangActing Managing DirectorLee HorobinGen Mgr:Finance
More Company Profile & Key Executives for PGLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil